13 valent Pneumococcal Polysaccharide Conjugate Vaccine (Chengdu Institute of Biological Products)

13价肺炎球菌多糖结合疫苗（成都生物研究所）

Report date: 2024/07/08 14:15:36

Base Information

Drug Name13 valent Pneumococcal Polysaccharide Conjugate Vaccine (Chengdu Institute of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChengdu Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsPneumococcal Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A